Morbidity and mortality rates associated with serial bleeding from the superficial temporal vein in mice

Lab Animal

Volumn 39, Issue 8, 2010, Pages 236-240

  Forbes, Nadine ^a   Brayton, Cory ^a   Grindle, Susan ^b   Shepherd, Starain ^a   Tyler, Betty ^a   Guarnieri, Michael ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; BLEEDING; FACE; FEMALE; HISTOLOGY; HUMAN; MORTALITY; MOUSE; PHLEBOTOMY; PHYSIOLOGY; SURVIVAL RATE; VASCULARIZATION; VEIN;

ANIMALS; FACE; FEMALE; HEMORRHAGE; HUMANS; MICE; MICE, INBRED BALB C; PHLEBOTOMY; SURVIVAL RATE; VEINS;

MUS;

EID: 77954842893     PISSN: 00937355     EISSN: 15484475     Source Type: Journal    
DOI: 10.1038/laban0810-236     Document Type: Article

References (14)

1. Hayward, A.M. et al. in The Mouse in Biomedical Research 2nd edn. (eds. Fox, J.G. et al.) vol.3, 454-458 (Academic, New York, 2006).
2. Hem, A., Smith, A.J. & Solberg, P. Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret, and mink. Lab. Anim. 32, 364-368 (1998).
3. Abatan, O.I., Welch, K.B. & Nemzek, J.A. Evaluation of saphenous venipuncture and modified tail-clip blood collection in mice. J. Am. Assoc. Lab. Anim. Sci. 47, 8-15 (2008).
4. Golde, W.T., Gollobin, P. & Rodriguez, L.L. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Anim. (NY) 34, 39-43 (2005).
5. Pontani, R.B. & Misra, A.L. A long-acting buprenorphine delivery system. Pharmacol. Biochem. Behav. 18, 471-474 (1983).
6. Institute for Laboratory Animal Research. Recognition and Alleviation of Pain in Laboratory Animals (National Academies Press, Washington DC, 2009).
7. Festing, M.F.W. Phenotypic variability of inbred and outbred mice. Nature 263, 230-232 (1976).
8. Lewis, J.W. in Buprenorphine: Combating Drug Abuse with a Unique Opioid (eds. Cowan, A. & Lewis, J.W.) 151-163 (Wiley-Liss, New York, 1995).
9. Gades, N.M., Danneman, P.J., Wixson, S.K. & Tolley, E.A. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Contemp. Top. Lab. Anim. Sci. 39, 8-13 (2000).
10. Christoph, T. et al. Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain. Eur. J. Pharmacol. 507, 87-98 (2005).
11. Kögel, B., Christoph, T., Strassburger, W. & Friderichs, E. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice. Eur. J. Pain 9, 599-611 (2005).
12. Pain Management in Animals (eds. Flecknell, P.A. & Waterman-Pearson, A.) (W.B. Saunders, London, 2000).
13. Schermer, S. The Blood Morphology of Laboratory Animals 61-74 (F.A. Davis Company, Philadelphia, 1967).
14. Guarnieri, M. et al. Toxicity of intercranial and intraperitoneal O6-benzyl guanine in combination with BCNU delivered locally in a mouse model. Cancer Chemother. Pharmacol. 50, 392-396 (2002).